Neonatal hypoglycemia screening in at-risk Australian infants

Hypoglycaemia remains one of the most frequent metabolic problems detected on postnatal wards in Australia, and prompt recognition protects a developing brain. The condition affects somewhere between 5 and 15 percent of otherwise healthy term babies and climbs considerably higher among preterm, growth-restricted, or infants of diabetic mothers. Because symptoms can be vague, ranging from jitteriness and poor feeding to apnoea, a structured approach to screening is far safer than relying on clinical signs alone. Missed episodes continue to feature in coronial findings and medico-legal reviews, which is why every state health department now mandates a written local protocol.

Australian maternity units operate across a remarkable spread of settings, from tertiary perinatal centres in Sydney and Melbourne to small district hospitals and remote clinics serviced by the Royal Flying Doctor Service. That diversity shapes how protocols for at-risk infants are written, taught and carried out. The aim of this article is to walk through the practical steps clinicians use to identify, screen and manage neonates who fall into the higher-risk categories, and to highlight the small but important differences that exist between state-based guidelines and tertiary hospital policies. Midwives, paediatric trainees and GPs in regional areas will find the most useful material in the middle sections, while unit leaders may want to compare the table with their own current flowchart.

Why neonatal hypoglycemia matters in the Australian setting

Untreated low blood glucose in the first days of life can lead to seizures, white matter injury and measurable deficits in school-age cognition. Paediatricians working in special care nurseries across Queensland, Victoria and Western Australia will tell you that the most defensible cases are the ones caught before symptoms appear. That is the whole logic behind universal screening of at-risk cohorts: targeted testing rather than reactive management. It is also the reason consultant neonatologists insist on documented pre-feed glucose values rather than informal bedside impressions.

The perinatal societies that informed earlier congresses, including the Federation of Asian and Oceania Perinatal Societies, also emphasised the overlap between neonatal metabolic care and the prevention of vertical infections. Readers following current perinatal infection prevention work will recognise the same principle: targeted surveillance of a defined cohort catches the problem before it becomes catastrophic. In Australia, the Australian and New Zealand Neonatal Network contributes data that helps benchmark how well local units are doing against this shared standard, and unit-level audit meetings routinely present glucose-screening compliance alongside other quality indicators.

Defining the at-risk infant locally

Australian guidelines, drawing heavily from the NHMRC-approved literature and the PCH, RWH and Royal Brisbane and Women's Hospital consensus statements, group at-risk infants into a recognisable cluster. The list includes babies born to mothers with diabetes (gestational or pre-existing), those large or small for gestational age, late preterm infants between 34 and 36+6 weeks, and any neonate whose mother received beta-blockers, oral hypoglycaemics or intravenous dextrose in labour. A history of perinatal asphyxia, rhesus disease and infants of mothers with untreated hyperthyroidism round out the usual list.

In practical terms, a midwife on a busy postnatal ward in Adelaide or Perth will usually tick off one of these boxes within the first hour of life and reach for the glucose strip. Useful clinical tools for bedside assessment, including structured documentation templates shared through international neonatal training resources, are freely available and help standardise the at-risk checklist between junior and senior staff. Education sessions run through the local health networks and the Australian College of Midwives regularly use these tools in their neonatal update workshops.

It is worth noting that Aboriginal and Torres Strait Islander mothers experience higher rates of gestational diabetes in some regions, which translates into a higher proportion of at-risk bubs in remote Western Australian and Northern Territory services. That makes the at-risk definition more than an academic exercise: it shapes staffing, glucose meter availability and the threshold for escalation. Culturally safe communication with families about why extra heel pricks are needed also matters, and several services now produce yarning-style information sheets to support that conversation.

When and how often to check blood glucose

The first feed should happen within the first hour, ideally skin-to-skin, and the first glucose check is recommended before the second feed, usually around three to four hours of age. Subsequent checks depend on the initial value and the ongoing risk profile. Most Australian protocols mirror the Pediatric Endocrine Society recommendations but with slightly more conservative thresholds for the first 24 hours, reflecting local concern about symptomatic thresholds in larger birth-weight babies.

A common schedule looks like this: pre-feed checks at 4, 8, 12 and 24 hours for asymptomatic at-risk infants, with additional readings if values are borderline. Symptomatic babies are tested immediately, regardless of timing. Documentation in the newborn observation chart, the same chart used for feeding and jaundice notes, keeps everything in one place for the next shift handover and ensures the GP and child health nurse have a continuous record on discharge.

State-based services often produce their own flowcharts. NSW Health, for instance, publishes a clear algorithm that aligns with the Australian and New Zealand Neonatal Network definitions, while Victoria's Royal Women's Hospital guidelines include slightly earlier intervention thresholds for the first four hours of life. The differences are small but they matter when a retrieval team is deciding whether to keep a baby in a level 2 nursery or call NETS for transfer. Smaller services in Tasmania and the ACT often adopt a hybrid of the nearest state guideline, with local modifications approved by their perinatal advisory committee.

Comparing bedside glucose meters and formal laboratory testing

The choice between a point-of-care glucometer and a formal blood gas or laboratory glucose is a daily decision in Australian postnatal wards. Each approach has trade-offs that influence how aggressively clinicians act on a low reading, and choosing the right one for the clinical context reduces both false reassurance and unnecessary intervention.

Method Turnaround Accuracy at low range Typical use Key limitation
Bedside glucometer (capillary) Under 1 minute ±0.5 to 1.0 mmol/L Routine screening, first 4 hours Up to 20 percent variance when glucose below 3 mmol/L
Blood gas analyser (arterial or venous) 2 to 5 minutes ±0.2 to 0.4 mmol/L Confirmatory testing, symptomatic infants Requires sample handling, equipment access
Laboratory plasma glucose 30 to 90 minutes Gold standard Retrospective confirmation, research Too slow for acute decision-making

Most Australian protocols treat the bedside reading as a screening tool only. If the value is below the intervention threshold, or if the infant is symptomatic, a confirmatory sample on the blood gas machine is the expected next step. The lab sample is reserved for cases where the clinical picture and the gas result disagree, or where a formal audit is underway.

Initial management and escalation pathways

Treatment follows a familiar stepwise ladder. For an asymptomatic baby with a glucose between 2.0 and 2.5 mmol/L, the first move is to support breastfeeding, offer a top-up of expressed breast milk or, where maternal supply is not yet established, a small volume of formula. Recheck within 30 to 60 minutes. If the value is below 2.0 mmol/L or the baby is symptomatic, buccal dextrose gel (typically 40 percent) is now standard practice across most public hospitals, supported by evidence from the Sugar Babies trial and adopted into state formularies under the PBS.

When gel and feeding fail to lift the glucose, the next step is admission to the special care nursery for an intravenous dextrose infusion, usually 10 percent at 4 to 6 mL/kg/hour. Escalation to a higher concentration or addition of a glucagon infusion is rare and usually happens under consultant guidance. Retrieval teams from NETS in NSW and the similar services in other states are contacted when a level 2 nursery cannot manage the escalation safely or when the infant requires a level 5 or 6 cot that is only available at a tertiary children's hospital.

Documentation throughout the escalation should be tight. The time of each reading, the feeding or treatment given and the response to that treatment are recorded in the medication chart alongside routine observations. Clear notes at this stage make the difference between a smooth retrieval and a confusing handover over the phone.

Discharge planning and community follow-up

Once a baby has maintained glucose targets for 24 hours on full enteral feeds, with no further readings below threshold, discharge planning begins. Parents need clear written advice on feeding frequency, signs that warrant a return to the emergency department, and the schedule for any follow-up appointments. The local child health nurse, often seen through the maternal and child health line in each state, plays a central role in the first weeks at home and is usually the first contact for a worried parent at 2 am.

For infants who required intravenous dextrose, a paediatric outpatient review is usually arranged at four to six weeks. A recent workshop on neuropsychological test errors is a useful reminder that subtle cognitive differences may not be apparent until school age. Local follow-up should include developmental milestones, hearing screening results and growth trajectory, with low threshold for referral to a paediatric endocrinologist when episodes were prolonged or recurrent.

Parents should also be told that an isolated hypoglycaemic episode in an at-risk infant rarely predicts future metabolic problems, but a pattern of low glucose across multiple feeds, or episodes after the first week of life, warrants paediatric review. Many services hand out a wallet-sized card summarising the readings and the management received, which the family can show to a GP in a different town if they move or travel.

Looking after bubs in rural and remote Australia

The further a family lives from a tertiary centre, the more important the front-end screening becomes. Royal Flying Doctor Service primary clinics and small district hospitals in the bush often hold limited stocks of dextrose gel and rely on point-of-care meters calibrated weekly by visiting laboratory staff. When a borderline reading occurs, the local clinician's decision is shaped by retrieval logistics, weather and the experience of the nurse on shift.

Telehealth consultations with tertiary neonatologists, increasingly funded through Medicare, have closed some of that gap. A midwife in Longreach or Broome can transmit a glucose trend, a feeding chart and a short video clip of the baby's tone within minutes, and receive an escalation plan back. She'll be right, as the saying goes, is not a clinical pathway, and Australian rural services have moved firmly away from informal reassurance toward documented thresholds and named retrieval contacts.

Aboriginal Community Controlled Health Organisations in places like the Kimberley and the Barkly Tablelands now partner with state retrieval services to provide culturally safe care for evacuated families, and the relationships built through that partnership have improved follow-up rates. For clinicians working outside the metropolitan teaching hospitals, regular scenario-based training with the local retrieval team is one of the most effective ways to keep protocols current and confidence high.

If you are a clinician, midwife or trainee looking to revisit the broader perinatal context that shaped many of these protocols, the archived FAOPS 2020 meeting site remains a useful reference point for plenary talks and abstracts that informed current regional practice.